GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (FRA:6QC) » Definitions » Market Cap

TOWA Pharmaceutical Co (FRA:6QC) Market Cap : €846 Mil (As of Jun. 04, 2024)


View and export this data going back to 2021. Start your Free Trial

What is TOWA Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TOWA Pharmaceutical Co's share price for the quarter that ended in Dec. 2023 was €14.9. TOWA Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 49 Mil. Therefore, TOWA Pharmaceutical Co's market cap for the quarter that ended in Dec. 2023 was €733 Mil.

TOWA Pharmaceutical Co's quarterly market cap increased from Jun. 2023 (€551 Mil) to Sep. 2023 (€881 Mil) but then declined from Sep. 2023 (€881 Mil) to Dec. 2023 (€733 Mil).

TOWA Pharmaceutical Co's annual market cap declined from Mar. 2022 (€1,017 Mil) to Mar. 2023 (€640 Mil) but then increased from Mar. 2023 (€640 Mil) to Mar. 2024 (€876 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TOWA Pharmaceutical Co's Enterprise Value for Today is €1,859 Mil.


TOWA Pharmaceutical Co Market Cap Historical Data

The historical data trend for TOWA Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Market Cap Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1,016.92 639.88 876.12

TOWA Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 639.88 551.28 881.07 733.37 876.12

Competitive Comparison of TOWA Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Market Cap falls into.



TOWA Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

TOWA Pharmaceutical Co's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=€17.8*49.2201
=€876

TOWA Pharmaceutical Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€14.9*49.2192
=€733

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TOWA Pharmaceutical Co  (FRA:6QC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


TOWA Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (FRA:6QC) Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (FRA:6QC) Headlines

No Headlines